These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38799468)

  • 21. A century of BCG: Impact on tuberculosis control and beyond.
    Ahmed A; Rakshit S; Adiga V; Dias M; Dwarkanath P; D'Souza G; Vyakarnam A
    Immunol Rev; 2021 May; 301(1):98-121. PubMed ID: 33955564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.
    Audran R; Karoui O; Donnet L; Soumas V; Fares F; Lovis A; Noirez L; Cavassini M; Fayet-Mello A; Satti I; McShane H; Spertini F
    J Infect; 2024 Aug; 89(2):106205. PubMed ID: 38897242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
    Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
    EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin.
    Woodworth JS; Clemmensen HS; Battey H; Dijkman K; Lindenstrøm T; Laureano RS; Taplitz R; Morgan J; Aagaard C; Rosenkrands I; Lindestam Arlehamn CS; Andersen P; Mortensen R
    Nat Commun; 2021 Nov; 12(1):6658. PubMed ID: 34795205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.
    Verreck FA; Vervenne RA; Kondova I; van Kralingen KW; Remarque EJ; Braskamp G; van der Werff NM; Kersbergen A; Ottenhoff TH; Heidt PJ; Gilbert SC; Gicquel B; Hill AV; Martin C; McShane H; Thomas AW
    PLoS One; 2009; 4(4):e5264. PubMed ID: 19367339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination.
    Guerra-Maupome M; McGill JL
    Sci Rep; 2019 Nov; 9(1):15996. PubMed ID: 31690788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.
    Mollenkopf HJ; Grode L; Mattow J; Stein M; Mann P; Knapp B; Ulmer J; Kaufmann SH
    Infect Immun; 2004 Nov; 72(11):6471-9. PubMed ID: 15501778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of advanced age on Mycobacterium bovis BCG vaccination in guinea pigs aerogenically infected with Mycobacterium tuberculosis.
    Komine-Aizawa S; Yamazaki T; Yamazaki T; Hattori S; Miyamoto Y; Yamamoto N; Haga S; Sugitani M; Honda M; Hayakawa S; Yamamoto S
    Clin Vaccine Immunol; 2010 Oct; 17(10):1500-6. PubMed ID: 20685935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
    Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
    Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination with Intradermal Bacillus Calmette-Guérin Provides Robust Protection against Extrapulmonary Tuberculosis but Not Pulmonary Infection in Cynomolgus Macaques.
    Tsujimura Y; Shiogama Y; Soma S; Okamura T; Takano J; Urano E; Murakata Y; Kawano A; Yamakawa N; Asaka MN; Matsuo K; Yasutomi Y
    J Immunol; 2020 Dec; 205(11):3023-3036. PubMed ID: 33097574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis vaccines: beyond bacille Calmette-Guerin.
    McShane H
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2782-9. PubMed ID: 21893541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG.
    Martín C; Marinova D; Aguiló N; Gonzalo-Asensio J
    Vaccine; 2021 Dec; 39(50):7277-7285. PubMed ID: 34238608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerosol immunization by alginate coated mycobacterium (BCG/MIP) particles provide enhanced immune response and protective efficacy than aerosol of plain mycobacterium against M.tb. H37Rv infection in mice.
    Nagpal PS; Kesarwani A; Sahu P; Upadhyay P
    BMC Infect Dis; 2019 Jul; 19(1):568. PubMed ID: 31262260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of mycobacterial protective immunity by sublingual BCG vaccination.
    Eickhoff CS; Blazevic A; Killoran EA; Morris MS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5364-5370. PubMed ID: 31331776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
    Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group
    Vaccine; 2015 Jun; 33(26):3047-55. PubMed ID: 25882170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.